Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus

Abroad (travel likely)RecruitingPHASE2

Conditions

Keratoconus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Glaukos Clinical Study Site, Westerville, Ohio, United States
Contact: Study coordinator (Study Manager) · 949-739-8749

Study leads

Study Director, MD
Study Director
Glaukos Corporation

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking in Eyes With Corneal Ectasia

Keratoconus · Pellucid Marginal Corneal Degeneration · Corneal Ectasia

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States

Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus

Progressive Keratoconus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Dothan, United States · Teaneck, United States

Safety and Effectiveness of the PXL-Platinum 330 System for Cornea Crosslinking in Eyes With Cornea Thinning

Keratoconus

Abroad (travel likely)RecruitingPHASE2

Boca Raton, United States

Corneal Elastography and Patient Specific Modeling

Cornea; Ectasia · Refractive Errors · Keratoconus

Abroad (travel likely)Recruiting

Cleveland, United States